Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy for Cancer Anxiety in Caregivers (FC-FORT Trial)
FC-FORT Trial Summary
This trial will study whether an online intervention designed to help reduce fear of cancer recurrence is feasible and acceptable for family caregivers, and if it has any clinical implications on those caregivers' fear of recurrence and quality of life.
FC-FORT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFC-FORT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FC-FORT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a high score on a test that measures fear of cancer coming back, indicating significant concerns about cancer recurrence.You are already part of another therapy or support group led by a therapist or peers.
- Group 1: CBT/Existential Group Therapy for Fear of Cancer Recurrence
- Group 2: Wait-list Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are engaged in this clinical experiment?
"Affirmative. Clinicaltrials.gov supports the fact that this study is presently enrolling participants, having first been posted on October 1st 2021 and updated most recently on October 26th 2022. With 36 patients being accepted across one medical centre."
What are the principal goals of this research?
"The primary objective of this clinical trial, which will be assessed after a period of 7 weeks, is to measure any changes in baseline fear of cancer recurrence at three months. To further evaluate the efficacy of this intervention, secondary outcomes include alterations in Group Cohesion (GCS), Cognitive Avoidance (CAQ) and Positive Beliefs About Worrying (WWQ). All these measures are scored on numerical scales ranging from 7-35 for GSC, 25-125 for CAQ and 13-65 for WWQ respectively. Higher scores represent stronger group cohesion or more positive beliefs about worrying while higher numbers on the CAQ indicate greater"
Are volunteers still being accepted for this clinical experiment?
"Affirmative, according to information published on clinicaltrials.gov this health investigation is actively searching for participants. The initial posting was made October 1st 2021 and the details were revised most recently on October 26th 2022. 36 people are needed from one site in order to complete the study."
Share this study with friends
Copy Link
Messenger